Latest news
March 5, 2020
Debiopharm Advances into the Highly Anticipated Clinical Phase for their Potent WEE1 Inhibitor
April 1, 2019
Debiopharm releases results of 3 key oncology compound programs at the 2019 American Association for Cancer Research (AACR) Conference in…
June 20, 2017
Almac Discovery and Debiopharm International SA Announce a Licensing Agreement for the Development of a Novel Wee-1 Inhibitor